Clinical Therapeutics
Volume 34, Issue 1 , Pages 24-36 , January 2012

Ulipristal Acetate: Review of the Efficacy and Safety of a Newly Approved Agent for Emergency Contraception

  • Ashley R. Richardson, PharmD, BCACP

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Ashley R. Richardson, PharmD, Division of Pharmacy Practice, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, 75 Dekalb Avenue, New York, NY 11201
    • ,
  • Fraidy N. Maltz, BS, PharmD

,Accepted 4 November 2011.

References 

  1. Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit . FFPRHC guidance: Emergency contraception . J Fam Plann Reprod Health Care . 2006;32:121–128
  2. Wilcox AJ , Weinberg CR , Baird DD . Timing of sexual intercourse in relation to ovulation (Effects on the probability of conception, survival of the pregnancy, and sex of the baby) . N Engl J Med . 1995;333:1517–1521
  3. Trussell J , Stewart F , Guest F , Hatcher RA . Emergency contractive pills: a simple proposal to reduce unintended pregnancies . Fam Plann Perspect . 1992;24:269–273
  4. Trussell J , Rodríguez G , Ellertson C . New estimates of the effectiveness of the Yuzpe regimen of emergency contraception . Contraception . 1998;57:363–369
  5. Orihuela PA . Ulipristal: a progesterone receptor antagonist as an emergency contraceptive . Expert Rev Obstet Gynecol . 2010;5:13–17
  6. Van Look PF , von Hertzen H . Emergency contraception . Br Med Bull . 1993;49:158–170
  7. Cheng L , Gülmezoglu A , Oel C , et al.  Interventions for emergency contraception . Cochrane Database Syst Rev . 2004;3: CD001324
  8. Cheng L , Gülmezoglu A , Piaggi G , et al.  Interventions for emergency contraception . Cochrane Database Syst Rev . 2008;2: CD001324
  9. Hatcher RA , A N . The menstrual cycle . In:  Hatcher RA ,  Trussell J ,  Stewart F editor. Contraceptive Technology . 18th ed.. New York, NY: Ardent Media; 2004;
  10. Gemzell-Danielsson K . Mechanism of action of emergency contraception . Contraception . 2010;82:404–409
  11. Dickerson LM , Shrader SP , Diaz VA . Contraception . In:  Dipiro JT ,  Talbert RL ,  Yee GC , et al. editor. Pharmacotherapy: A Pathophysiologic Approach . 7th ed.. New York, NY: McGraw Medical; 2008;p. 1313–1327
  12. Stanford J , Mikolajczyk R . Mechanisms of action of intrauterine device: update and estimation of postfertilization effects . Am J Obstet Gynecol . 2002;187:1699–1708
  13. Trussell J , Leveque J , Wysocki S , et al.  The economic value of contraception a comparison of 15 methods . Am J Public Health . 1995;85:494–503
  14. Zhou L , Xiao B . Emergency contraception with multi-load cu-375 SL IUD: a multicenter clinical trial . Contraception . 2001;64:107–112
  15. World Health Organization (WHO) . In: Selected Practice Recommendations for Contraceptive Use . 2nd ed.. Geneva, Switzerland: WHO; 2004;
  16. The American College of Obstetricians and Gynecologists, Women's Health Care Physicians . Emergency contraception (Practice bulletin no. 112) . Obstet Gynecol . 2010;115:1100–1109
  17. Centers for Disease Control and Prevention . US medical eligibility criteria for contraceptive use (adapted from the World Health Organization medical eligibility criteria for contraceptive use, 4th ed) . Updated 2010 www.cdc.gov/mmwr/preview/mmwrhtml/rr59e0528a1.htm Accessed March 1, 2011
  18. Grimes D . Intrauterine devices . In:  Hatcher RA ,  Trussell J ,  Nelson AL , et al. editor. Contraceptive Technology . 18th ed.. New York, NY: Ardent Media; 2004;p. 499–502
  19. Morris JM , Van Wagenen G . Compounds interfering with ovum implantation and development: the role of estrogens . Am J Obstet Gynecol . 1966;15:804–815
  20. Yuzpe AA , Thurlow HJ , Ramzy I , Leyshon JI . Post coital contraception: a pilot study . J Reprod Med . 1974;13:53–58
  21. WHO Task Force on Postovulatory Methods of Fertility Regulation . Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception . Lancet . 1998;352: 428–422
  22. Glasier A , Cameron S , Gainer E , et al.  Ulipristal acetate versus levonorgestrel for emergency contraception: a randomized non-inferiority trial and meta-analysis . Lancet . 2010;375:555–562
  23. Gemzell-Danielsson K , Meng CX . Emergency contraception: potential role of ulipristal acetate . Int J Womens Health . 2010;2:53–61
  24. Piaggio G , von Hertzen H , Grimes D , Van Look P  Task force on postovulatory methods of fertility regulation . Timing of emergency contraception with levonorgestrel or the Yuzpe regimen . Lancet . 1999;353:721
  25. Glasier A . Emergency postcoital contraception . N Engl J Med . 1997;337:1058–1064
  26. Glasier A , Thong KJ , Dewar M , et al.  Mifepristone (RU486) compared with high dose estrogen and progestin for emergency postcoital contraception . N Engl J Med . 1992;327:1041–1044
  27. Fine P , Mathe H , Ginde S , et al.  Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception . Obstet Gynecol . 2010;115:257–263
  28. Ella [package insert] . Morristown, NJ: Watson Pharmaceuticals; August 2010; http://dailymed.nlm.nih.gov.cwplib.proxy.liu.edu/dailymed/drugInfo.cfm?id=14292 Accessed March 12, 2011
  29. Next Choice [package insert] . Corona, Calif: Watson Laboratories; December 2009; http://dailymed.nlm.nih.gov.cwplib.proxy.liu.edu/dailymed/drugInfo.cfm?id=14292 Accessed March 12, 2011
  30. Plan B [package insert] . Pomona, Calif: Duramed Pharmaceuticals; July 2009; http://dailymed.nlm.nih.gov.cwplib.proxy.liu.edu/dailymed/drugInfo.cfm?id=15270 Accessed March 12, 2011
  31. Plan B One-Step [package insert] . Pomona, CA: Duramed Pharmaceuticals; August 2009; http://dailymed.nlm.nih.gov.cwplib.proxy.liu.edu/dailymed/drugInfo.cfm?id=12895 Accessed March 12, 2011
  32. Levens E , Potlog-Nahari C , Nieman L , et al.  CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial . Obstet Gynecol . 2008;111:1129–1136
  33. US Food and Drug Administration . Ulipristal acetate: new drug review application 22-474 . Center for Drug Evaluation and Research . 2009;
  34. Creinin M , Schlaff W , Archer DF , et al.  Progestin receptor modulator for emergency contraception: a randomized control trial . Obstet Gynecol . 2006;108:1089–1097
  35. Wagner BL , Polio G , Giangrande P , et al.  The novel progesterone receptor antagonist RTI 3021-3012 and RTI 3021-3022 exhibit complex glucocorticoid receptor activities: implications for the development of dissociated antiprogestins . Endocrinology . 1999;140:1449–1458
  36. Attardi BJ , Burgenson J , Hild SA , Reel JR . In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone . J Steroid Biochem Mol Biol . 2004;88:277–288
  37. Attardi BJ , Burgenson J , Hild SA , et al.  CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914 . Mol Cell Endocrinol . 2002;188:111–123
  38. Blithe DL , Nieman LK , Blye RP , et al.  Development of the selective progesterone receptor modulator CDB-2914 for clinical indications . Steroids . 2003;68:1013–1017
  39. Cook CE , Raje P , Lee DY , Kepler JA . Effect of 17alpha-(3-hydroxypropyl)-17beta-acetyl substituents pattern on the glucocorticoid and progestin receptor binding of 11beta-arylestra-4,9-dien-3-ones . Org Lett . 2001;3:1013–1016
  40. Gainer EE , U A . Pharmacologic properties of CDB(VA)-2914 . Steroids . 2003;68:1005–1011
  41. Rao PN , Wang Z , Cessac JW , et al.  New 11beta-aryl-substituted steroids exhibit both progestational and antiprogestational activity . Steroids . 1998;63:523–530
  42. Brache V , Cochon L , Jesam C , et al.  Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture . Hum Reprod . 2010;25:2256–2263
  43. Stratton P , Hartog B , Hajizadeh N , et al.  A single mid-follicular dose of CDB-2914, a new antiprogestin, inhibits folliculogenesis and endometrial differentiation in normally cycling women . Hum Reprod . 2000;15:1092–1099
  44. Stratton P , Levens ED , Hartog B , et al.  Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914 . Fertil Steril . 2010;93:2035–2041
  45. Red Book Online (internet database) . Greenwood Village, Colo: Thomson Reuters (Healthcare) Inc. Updated periodically http://www.thomsonhc.com Accessed July 20, 2011

PII: S0149-2918(11)00729-6

doi: 10.1016/j.clinthera.2011.11.012

Clinical Therapeutics
Volume 34, Issue 1 , Pages 24-36 , January 2012

Article Tools

* Image Usage & Resolution